Silk Road Medical Stock Cash And Equivalents
| SILKDelisted Stock | USD 27.49 0.00 0.00% |
Silk Road Medical fundamentals help investors to digest information that contributes to Silk Road's financial success or failures. It also enables traders to predict the movement of Silk Stock. The fundamental analysis module provides a way to measure Silk Road's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Silk Road stock.
Silk |
Silk Road Medical Company Cash And Equivalents Analysis
Silk Road's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Silk Road Cash And Equivalents | 108.87 M |
Most of Silk Road's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Silk Road Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
CompetitionIn accordance with the recently published financial statements, Silk Road Medical has 108.87 M in Cash And Equivalents. This is 86.74% lower than that of the Health Care Equipment & Supplies sector and 80.49% lower than that of the Health Care industry. The cash and equivalents for all United States stocks is 95.97% higher than that of the company.
Silk Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Silk Road's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Silk Road could also be used in its relative valuation, which is a method of valuing Silk Road by comparing valuation metrics of similar companies.Silk Road is currently under evaluation in cash and equivalents category among its peers.
Silk Fundamentals
| Return On Equity | -0.36 | |||
| Return On Asset | -0.14 | |||
| Profit Margin | (0.30) % | |||
| Operating Margin | (0.34) % | |||
| Current Valuation | 1.02 B | |||
| Shares Outstanding | 40.63 M | |||
| Shares Owned By Insiders | 4.15 % | |||
| Shares Owned By Institutions | 97.46 % | |||
| Number Of Shares Shorted | 3.15 M | |||
| Price To Book | 7.22 X | |||
| Price To Sales | 5.83 X | |||
| Revenue | 177.13 M | |||
| Gross Profit | 100.76 M | |||
| EBITDA | (55.48 M) | |||
| Net Income | (55.74 M) | |||
| Cash And Equivalents | 108.87 M | |||
| Cash Per Share | 3.09 X | |||
| Total Debt | 84.63 M | |||
| Debt To Equity | 1.37 % | |||
| Current Ratio | 6.92 X | |||
| Book Value Per Share | 3.81 X | |||
| Cash Flow From Operations | (32.01 M) | |||
| Short Ratio | 2.48 X | |||
| Earnings Per Share | (1.45) X | |||
| Price To Earnings To Growth | (0.26) X | |||
| Target Price | 20.75 | |||
| Number Of Employees | 474 | |||
| Beta | 1.54 | |||
| Market Capitalization | 1.12 B | |||
| Total Asset | 265.31 M | |||
| Retained Earnings | (399.45 M) | |||
| Working Capital | 210.55 M | |||
| Net Asset | 265.31 M |
About Silk Road Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Silk Road Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Silk Road using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Silk Road Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in Silk Stock
If you are still planning to invest in Silk Road Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Silk Road's history and understand the potential risks before investing.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |